KRT17 Antibody

SKU: orb1252034

Description

KRT17 Antibody

Research Area

Cancer Biology

Images & Validation

• Tested Applications: IF, IHC-P
• Reactivity: Human
• Application Notes:
  Immunofluorescence: 1-2 µg/mLImmunohistochemistry (FFPE): 1-2 µg/mL for 30 min at RT (1)Prediluted format : incubate for 30 min at RT (2)Titering of the Cytokeratin 17 antibody may be required for optimal performance.1. FFPE testing requires sections to be boiled in pH6 10mM citrate buffer for 10-20 minutes, followed by cooling at RT for 20 minutes, prior to staining.2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

Key Properties

• Antibody Type: Primary Antibody
• Host: Mouse
• Clonality: Monoclonal
• Isotype: IgG2b, kappa
• Clone No.: CTKN17-1
• Immunogen: Recombinant full-length human KRT17 protein was used as the immunogen for the Cytokeratin 17 antibody.
• Target: KRT17
• Purification: Protein G affinity chromatography
• Conjugation: Unconjugated

Storage & Handling

• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Form/Appearance: Liquid
• Buffer/Preservatives: PBS with 0.1 mg/ml rAlbumin and 0.05% sodium azide
• Concentration: 0.2 mg/mL
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

KRT17, K17, PC, PC2, PCHC1

IHC testing of FFPE cervical carcinoma and Cytokeratin 17 antibody.

IHC testing of FFPE bladder carcinoma and Cytokeratin 17 antibody.

Quick Database Links

Gene Symbol

KRT17

UniProt

Q04695